Back to Research

Organization profile

Axenoll Life Sciences

Axenoll Life Sciences is a technology company that utilizes patented 3D screen printing to manufacture high-resolution medical and life science products. The organization enables the industrial-scale production of bioprinted scaffolds, microfluidic chips, and advanced wound dressings through a gentle, low-temperature additive manufacturing process.43

Zurich, SwitzerlandFounded 2014

Overview

1. Executive Summary (Confidence: High)

Axenoll Life Sciences AG is a pioneer in the industrialization of "3D Mass Customization®". Based in Zurich, Switzerland, with a high-tech manufacturing site in Jena, Germany, the company holds the global license for a unique 3D screen printing technology. Unlike conventional bioprinting, which is often slow and unsuitable for mass production, Axenoll’s process allows for the rapid, parallel processing of thousands of items with sub-20 µm resolution. This "gentle" technology is specifically designed to handle sensitive biological materials, including living cells and peptides, making it an ideal partner for the MedTech, cosmetics, and pharmaceutical industries. Backed by an $8.26 million venture capital round, Axenoll serves as a comprehensive OEM partner, managing product development from initial idea to GMP-compliant serial production.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.